- Home
- UFG vs TELO Comparison
UFG vs TELO Comparison
Compare UFG & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFG
- TELO
- Stock Information
- Founded
- UFG 2021
- TELO 2021
- Country
- UFG Singapore
- TELO United States
- Employees
- UFG N/A
- TELO N/A
- Industry
- UFG Oil Refining/Marketing
- TELO
- Sector
- UFG Energy
- TELO
- Exchange
- UFG Nasdaq
- TELO NYSE
- Market Cap
- UFG 136.4M
- TELO 154.1M
- IPO Year
- UFG 2025
- TELO 2024
- Fundamental
- Price
- UFG $4.39
- TELO $3.91
- Analyst Decision
- UFG
- TELO
- Analyst Count
- UFG 0
- TELO 0
- Target Price
- UFG N/A
- TELO N/A
- AVG Volume (30 Days)
- UFG 166.1K
- TELO 121.1K
- Earning Date
- UFG 01-01-0001
- TELO 02-04-2025
- Dividend Yield
- UFG N/A
- TELO N/A
- EPS Growth
- UFG N/A
- TELO N/A
- EPS
- UFG 0.02
- TELO N/A
- Revenue
- UFG $130,669,390.00
- TELO N/A
- Revenue This Year
- UFG N/A
- TELO N/A
- Revenue Next Year
- UFG N/A
- TELO N/A
- P/E Ratio
- UFG $225.13
- TELO N/A
- Revenue Growth
- UFG 129.69
- TELO N/A
- 52 Week Low
- UFG $3.82
- TELO $3.11
- 52 Week High
- UFG $5.10
- TELO $9.54
- Technical
- Relative Strength Index (RSI)
- UFG N/A
- TELO 40.31
- Support Level
- UFG N/A
- TELO $3.75
- Resistance Level
- UFG N/A
- TELO $4.83
- Average True Range (ATR)
- UFG 0.00
- TELO 0.32
- MACD
- UFG 0.00
- TELO -0.05
- Stochastic Oscillator
- UFG 0.00
- TELO 13.01
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.